Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.

Skaland I, van Diest PJ, Janssen EA, Gudlaugsson E, Baak JP.

Hum Pathol. 2008 Apr;39(4):584-90. doi: 10.1016/j.humpath.2007.08.016. Epub 2008 Mar 4.

PMID:
18291440
2.

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

Skaland I, Janssen EA, Gudlaugsson E, Klos J, Kjellevold KH, Søiland H, Baak JP.

Mod Pathol. 2007 Dec;20(12):1307-15. Epub 2007 Oct 5.

3.

Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.

Baak JP, Colpaert CG, van Diest PJ, Janssen E, van Diermen B, Albernaz E, Vermeulen PB, Van Marck EA.

Eur J Cancer. 2005 Sep;41(14):2093-101.

PMID:
16153819
5.

Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.

Baak JP, van Diest PJ, Voorhorst FJ, van der Wall E, Beex LV, Vermorken JB, Janssen EA.

J Clin Oncol. 2005 Sep 1;23(25):5993-6001.

PMID:
16135467
7.

The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.

Baak JP, van Diest PJ, Voorhorst FJ, van der Wall E, Beex LV, Vermorken JB, Janssen EA, Gudlaugsson E; other collaborators of the Multicenter Morphometric Mammary Carcinoma Project (MMMCP)..

Eur J Cancer. 2007 Feb;43(3):527-35. Epub 2006 Nov 15.

PMID:
17110097
8.
9.

In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.

Bult P, Manders P, Straatman HM, Tjan-Heijnen VC, Beex LV, Hendriks J, Leer JW, Verbeek AL, Holland R.

Breast Cancer Res Treat. 2010 Jul;122(1):77-86. doi: 10.1007/s10549-009-0526-7. Epub 2009 Sep 17.

PMID:
19760038
10.
11.

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.

Baak JP, Gudlaugsson E, Skaland I, Guo LH, Klos J, Lende TH, Søiland H, Janssen EA, Zur Hausen A.

Breast Cancer Res Treat. 2009 May;115(2):241-54. doi: 10.1007/s10549-008-0126-y. Epub 2008 Jul 30. Review.

PMID:
18665447
12.
13.

Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.

Tawfik O, Kimler BF, Davis M, Stasik C, Lai SM, Mayo MS, Fan F, Donahue JK, Damjanov I, Thomas P, Connor C, Jewell WR, Smith H, Fabian CJ.

Virchows Arch. 2007 Jun;450(6):627-36. Epub 2007 Apr 26.

PMID:
17458558
14.

Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer.

Uyterlinde AM, Schipper NW, Baak JP, Peterse H, Matze E.

Am J Clin Pathol. 1988 Mar;89(3):301-7.

PMID:
2831704
15.

Mitotic activity index in interval breast cancers.

Groenendijk RP, Bult P, Noppen CM, Boetes C, Ruers TJ, Wobbes T.

Eur J Surg Oncol. 2003 Feb;29(1):29-31.

PMID:
12559073
16.

Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours.

Fiets WE, Bellot FE, Struikmans H, Blankenstein MA, Nortier JW.

Eur J Surg Oncol. 2005 Mar;31(2):128-33.

PMID:
15698727
17.
18.

Role of mitotic counts in the grading and prognosis of the breast cancer.

Patel C, Sidhu KP, Shah MJ, Patel SM.

Indian J Pathol Microbiol. 2002 Jul;45(3):247-54.

19.

Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.

Meyer JS, Alvarez C, Milikowski C, Olson N, Russo I, Russo J, Glass A, Zehnbauer BA, Lister K, Parwaresch R; Cooperative Breast Cancer Tissue Resource..

Mod Pathol. 2005 Aug;18(8):1067-78. Erratum in: Mod Pathol. 2005 Dec;18(12):1649.

20.

Influence of age and prognosis of breast cancer in Nigeria.

Ikpat OF, Ndoma-Egba R, Collan Y.

East Afr Med J. 2002 Dec;79(12):651-7.

PMID:
12678449

Supplemental Content

Support Center